pharmaceutical investing New Study Shows Potential for Drug Developed to treat Major Depressive Disorder
Neuralstem Announces the Closing of $20 Million Strategic Investment from Tianjin Pharmaceutical Group International Holdings
Sun Summit Commences 2025 Exploration Program at the JD Project, Toodoggone District, British Columbia